YILDIRIM, H. Et Al. 2022. Evaluation of effect of nilotinib in an experimental corneal neovascularization model.. Anatolian Current Medical Journal , vol.4, no.4 , 431-437.

YILDIRIM, H., BALBABA, M., ERDAĞ, M., CANLEBLEBİCİ, M., DAL, A., İLHAN, N., ... ERÖKSÜZ, Y.(2022). Evaluation of effect of nilotinib in an experimental corneal neovascularization model.. Anatolian Current Medical Journal , vol.4, no.4, 431-437.

YILDIRIM, HAKAN Et Al. "Evaluation of effect of nilotinib in an experimental corneal neovascularization model.," Anatolian Current Medical Journal , vol.4, no.4, 431-437, 2022

YILDIRIM, HAKAN Et Al. "Evaluation of effect of nilotinib in an experimental corneal neovascularization model.." Anatolian Current Medical Journal , vol.4, no.4, pp.431-437, 2022

YILDIRIM, H. Et Al. (2022) . "Evaluation of effect of nilotinib in an experimental corneal neovascularization model.." Anatolian Current Medical Journal , vol.4, no.4, pp.431-437.

@article{article, author={HAKAN YILDIRIM Et Al. }, title={Evaluation of effect of nilotinib in an experimental corneal neovascularization model.}, journal={Anatolian Current Medical Journal}, year=2022, pages={431-437} }